Webinar: Tuberculosis, current status update from ongoing research collaborations within the AMR Accelerator (AMR Accelerator Members Only)

ONLINE WEBINAR RI

About fifteen people attended this webinar which provided the most recent updates of ongoing TB research within the IMI AMR Accelerator. The following speakers addressed the challenges of their respective TB projects: Michael Hoelscher (Medical University München) who gave an update and intro to UNITE4TB; Santiago Ferrer-Bazaga (Universidad Carlos III Madrid) who discussed some challenges […]

AMR Accelerator Cross-project Meeting (AMR Accelerator Members Only)

Basel, Switzerland

The 3rd AMR Accelerator Cross-project Meeting for the AMR Accelerator community, a total of 9  projects, took place on 06 April 2022 in Basel, Switzerland. Please find more details here and the final agenda below:     DOWNLOAD THE FULL PROGRAMME HERE   DOWNLOAD THE PRESENTATIONS HERE

COMBINE Expert Workshop on Monoclonal Antibodies for AMR Pathogens

Online

In June 2022, the Paul-Ehrlich-Institut organised a two-day virtual expert workshop on behalf of the COMBINE project. The workshop aimed to address the challenges in developing monoclonal antibodies (mAbs) against antimicrobial resistance (AMR) pathogens, with a specific focus on ESCAPE pathogens (E. faecium, S. aureus, C. difficile, A. baumannii, P. aeruginosa, and Enterobacteriaceae). The workshop […]

UNITE4TB webinar: Progress made to date in shortening TB treatment

Online

Recap of the third UNITE4TB webinar: Progress made to date in shortening TB treatment UNITE4TB held its third public webinar on Thursday 7 July, with a focus on the recent changes in the World Health Organization (WHO) guidelines for the treatment of Tuberculosis (TB) and an evaluation of the evidence underpinning the shortening of TB […]

Tuberculosis, current status update from ongoing research collaborations within the AMR Accelerator (AMR Accelerator Members only)

Online

About twenty people attended this webinar which focused on some highlights and challenges from three TB focused projects, namely UNITE4TB, ERA4TB, and TRIC-TB. The selected speakers, Modesto Remuinan-Blanco (TRIC-TB and GSK), Martin Boeree (UNITE4TB and Radboud UMC), Alfonso Mendoza-Losana (ERA4TB and Universidad Carlos III Madrid) and Oscar della Pasqua (ERA4TB and Consiglia Nazionale delle Ricerche) […]

ERA4TB Webinar on Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives

Online

ERA4TB launched a series of webinars aimed at exploring key topics in relation to tuberculosis and antimicrobial research and development from clinical, regulatory and HTA perspectives. With the title “Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives”, the first webinar was held on 24th November 2022, 11.00-12.15 GMT coinciding with World Antimicrobial Awareness […]

Machine Learning Science Interest Group Kick-off Meeting (AMR Accelerator Members only)

Online

About fifteen people attended the kick-off meeting of the Scientific Interest Group (SIG) on machine learning (ML). First, all attendees introduced themselves and outlined their interest in ML. Frederik Deroose, SIG Chairman, Connecting Pharma (ex-Asclepia Outsourcing Solutions) and Philip Gribbon, SIG Leader, Fraunhofer ITMP introduced the ML Scientific Interest Group (SIG) and its charter. Daniel […]

Science Interest Group on Animal Models – Kick-off Meeting (AMR Accelerator Members only)

Online

About fifteen people attended the kick-off meeting of the Scientific Interest Group (SIG) on animal models. First, all attendees introduced themselves and outlined which models they currently use in their project. Frederik Deroose, SIG Chairman, Connecting Pharma (ex-Asclepia Outsourcing Solutions), SIG Chairman and Carina Vingsbo Lundberg, SIG Leader, Statens Serum Institut introduced the Animal Models […]